NASDAQ
Kymera Therapeutics, Inc. (KYMR) has a eps (basic) of $-3.69 as of Wednesday, December 31, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.